Biodistribution of Tc-99m-BTG-N4 - a retrospective evaluatio
- Conditions
- C61Malignant neoplasm of prostate
- Registration Number
- DRKS00030296
- Lead Sponsor
- Klinik für Nuklearmedizin, Universitätsklinikum Augsburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 5
Inclusion Criteria
Histologically confirmed prostate carcinoma and an examination with 99mTc-BTG-N4
Exclusion Criteria
None
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The aim of the retrospective analysis is to determine the biodistribution of the GRPR ligand 99mTc-BTG-N4 and in particular the radiation dose for organs and the whole body.<br>time period: 05.07.2021 - 20.07.2022<br>Method: The Volume of Interest is drawn around the corresponding organs and the activity concentration in the different acquired images is determined. Other clinical parameters and the activity values show the residence time of the radiopharmaceutical in the individual organs.<br><br>
- Secondary Outcome Measures
Name Time Method